anmelden
SPI
18.574,54
PKT
-62,04
PKT
-0,33
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.04.14 | Nestlé Outperform | Bernstein Research | |
| 02.04.14 | Roche buy | Deutsche Bank AG | |
| 02.04.14 | Novartis Hold | Deutsche Bank AG | |
| 01.04.14 | Givaudan overweight | JP Morgan Chase & Co. | |
| 01.04.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 01.04.14 | Roche overweight | JP Morgan Chase & Co. | |
| 01.04.14 | Novartis buy | UBS AG | |
| 31.03.14 | UBS overweight | JP Morgan Chase & Co. | |
| 28.03.14 | Novartis buy | UBS AG | |
| 28.03.14 | Nestlé Neutral | Credit Suisse Group | |
| 27.03.14 | Nestlé Neutral | UBS AG | |
| 26.03.14 | Novartis Neutral | JP Morgan Chase & Co. | |
| 26.03.14 | Novartis buy | UBS AG | |
| 26.03.14 | Nestlé Hold | Deutsche Bank AG | |
| 25.03.14 | UBS buy | UBS AG | |
| 24.03.14 | Swiss Re Underperform | Bernstein Research | |
| 24.03.14 | Holcim Sell | Goldman Sachs Group Inc. | |
| 24.03.14 | Novartis buy | UBS AG | |
| 21.03.14 | Roche buy | Deutsche Bank AG | |
| 21.03.14 | Novartis buy | UBS AG | |
| 20.03.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 20.03.14 | UBS Neutral | Macquarie Research | |
| 20.03.14 | UBS Outperform | Macquarie Research | |
| 19.03.14 | Novartis Hold | Jefferies & Company Inc. | |
| 17.03.14 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 14.03.14 | Roche overweight | JP Morgan Chase & Co. | |
| 14.03.14 | Roche overweight | Morgan Stanley | |
| 14.03.14 | Novartis Underweight | Morgan Stanley | |
| 14.03.14 | Holcim Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.03.14 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.03.14 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 12.03.14 | Zurich Insurance neutral | Bernstein Research | |
| 11.03.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 10.03.14 | UBS overweight | Morgan Stanley | |
| 10.03.14 | Novartis Underweight | Barclays Capital | |
| 10.03.14 | Roche overweight | Barclays Capital | |
| 10.03.14 | UBS buy | Citigroup Corp. | |
| 07.03.14 | Holcim Neutral | UBS AG | |
| 06.03.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 06.03.14 | Roche overweight | JP Morgan Chase & Co. |